These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12637458)

  • 1. Lymph node dissection: is it diagnostic or therapeutic?
    Sigurdson ER
    J Clin Oncol; 2003 Mar; 21(6):965-7. PubMed ID: 12637458
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of locoregional treatment.
    Lawrence GA; Crawford J
    J Clin Oncol; 2003 Dec; 21(24):4660-1; author reply 4661-2. PubMed ID: 14673067
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sentinel node biopsy expands.
    Peres J
    J Natl Cancer Inst; 2013 Oct; 105(19):1423-4. PubMed ID: 24052620
    [No Abstract]   [Full Text] [Related]  

  • 5. Axillary dissection: current practice and technique.
    Petrek JA; Blackwood MM
    Curr Probl Surg; 1995 Apr; 32(4):257-323. PubMed ID: 7705102
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical impact of extracapsular extension of axillary lymph node metastases in breast cancer].
    Zhang B; Cao WF; Zhao HM; Song YQ; Ning LS; Niu Y; Hao XS; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):790-4. PubMed ID: 20021837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLN biopsy for large and/or multicentric breast cancers: should we worry?
    Cody HS
    Eur J Surg Oncol; 2011 May; 37(5):386-7. PubMed ID: 21388775
    [No Abstract]   [Full Text] [Related]  

  • 9. Is regional nodes radiotherapy an alternative to surgery?
    Offersen BV; Nielsen HM; Overgaard M; Overgaard J
    Breast; 2013 Aug; 22 Suppl 2():S118-28. PubMed ID: 24074772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
    Moffat FL
    J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
    [No Abstract]   [Full Text] [Related]  

  • 11. The current role of sentinel node biopsy in the treatment of breast cancer.
    Grube BJ; Giuliano AE
    Adv Surg; 2004; 38():121-66. PubMed ID: 15515617
    [No Abstract]   [Full Text] [Related]  

  • 12. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
    Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
    Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
    Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
    Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of micrometastasis in sentinel lymph nodes.
    Ozcinar B; Muslumanoglu M; Igci A; Gurdal SO; Yavuz E; Kecer M; Dagoglu T; Ozmen V
    Breast; 2011 Feb; 20(1):31-3. PubMed ID: 20846864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with breast cancer and positive sentinel nodes: axillary dissection or axillary radiotherapy?
    Zippel D; Papa M
    Arch Surg; 2003 Oct; 138(10):1159. PubMed ID: 14557139
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the essential element(s) to avoid axillary involvement in breast cancer patients?
    Akbari ME; Hassani M; Akbari A; Nafisi N; Naserinia SS; Jafari R; Razaghi Z
    Breast J; 2013; 19(1):121-3. PubMed ID: 23279445
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer: can axillary lymph node dissection be avoided?
    Barry M; Kell MR
    Eur J Surg Oncol; 2012 Jan; 38(1):6-7. PubMed ID: 22014429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.